Contract 75N94020D00004
Boston Medical Center Corporation · Department Of Health And Human Services · July 1, 2026
Boston Medical Center Corporation was awarded a federal contract by Department Of Health And Human Services (National Institutes Of Health) on July 1, 2026 for an undisclosed amount of work in research and development in biotechnology (except nanobiotechnology). It was awarded under full and open competition. It uses cost no fee contract pricing. If all options are exercised, the contract could reach $5.00 million.
Contract details
- PIID
- 75N94020D00004
- Award type
- —
- Pricing
- Cost No Fee
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 541714 · Research And Development In Biotechnology (Except Nanobiotechnology)
- Product / service
- Health R&D Services; Health Care Services; Applied Research
- First action
- July 1, 2026
Description
NICHD: R&D: TO CONDUCT PHASE I, II, III OR IV CONTRACEPTIVE TRIALS IN WOMEN, TREATMENT TRIALS OF GYNECOLOGIC CONDITIONS SUCH AS ENDOMETRIOSIS OR LEIOMYOMATA, AND DEVELOPMENT OF RESEARCH PROTOCOLS ON A TASK ORDER BASIS: NON-SEVERABLE
Modification timeline
-
July 1, 2026Mod P00002 · Other Administrative Action$0
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Battelle Memorial Institute | Department Of Health And Human Services | July 2, 2026 | $6.28M |
| Glaxosmithkline, Llc | Department Of Health And Human Services | July 2, 2026 | $597.8K |
| Medigen, Inc. | Department Of Health And Human Services | July 2, 2026 | $2.18M |
| American Type Culture Collection | Department Of Health And Human Services | July 1, 2026 | $855.4K |
| Battelle Memorial Institute | Department Of Health And Human Services | July 1, 2026 | $11.71M |
| Battelle Memorial Institute | Department Of Health And Human Services | July 1, 2026 | $3.49M |
Top contractors in NAICS 541714
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Amgen USA Inc | 1 | $59.99M |
| 2 | Vericel Corporation | 1 | $34.88M |
| 3 | Spectral Md, Inc. | 1 | $31.67M |
| 4 | Ppd Development Lp | 6 | $31.12M |
| 5 | L3 Technologies, Inc. | 1 | $22.00M |
| 6 | Technical Resources International, Inc. | 6 | $21.80M |
| 7 | Abbott Laboratories | 1 | $21.01M |
| 8 | Paratek Pharmaceuticals, Inc | 1 | $17.47M |
| 9 | Ossium Health, Inc. | 1 | $12.39M |
| 10 | Rho Federal Systems Division Inc | 1 | $8.00M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75N94020D00004?
Contract 75N94020D00004 is a federal contract awarded to Boston Medical Center Corporation by Department Of Health And Human Services on July 1, 2026 for an undisclosed amount of work classified under RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY). It has been modified 0 times since the base award.
Who won contract 75N94020D00004?
Boston Medical Center Corporation won contract 75N94020D00004 from Department Of Health And Human Services.
How much is contract 75N94020D00004 worth?
Contract 75N94020D00004 has obligated $0 to date but carries a potential ceiling of $5.00 million if fully funded and all options are exercised.